Page 13 - Ryan Leng News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Two players won gold bracelets while Phil Hellmuth reached the final table of the $25,000 H.O.R.S.E. on Day 2 of the 2021 World Series of Poker.

After topping 958 entries, Bryan “ Pellepelle” Piccioli was the last person standing. He nabbed $83,332 for his efforts and his second bracelet. This turbo event finished up in about seven hours.  Piccioli has more than $1.6 million for his sixth-place finish in the WSOP Main Event in 2017.  Darren “ darrenelias” Elias also scored a final table appearance, finishing fifth for $18,729. Other notable cashes included Shannon “aulophobia” Shorr, Katie “katelin” Lindsay, and Michigan’s Ryan “Bitcoin” Riess. Daniel “Dnegs” Negreanu also had his fourth cash of the se...

Adlai Nortye Raises $100 Million in Series D Financing Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures BriefingWire.com, 7/15/2021 - NEW JERSEY and HANGZHOU, CHINA, July 15, 2021 - (ACN Newswire) - Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology dr*gs, today announced the completion of $100 million Series D financing round. Co-led by SDIC ...

(1) NEW JERSEY and HANGZHOU, CHINA, July 15, 2021 - (ACN Newswire) - Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. Co-led by SDIC Fund Management and Tigermed, this round of financing is participated by Legend Star, Wuxi Biologicals Healthcare Ventures, Triwise Capital, Qingdao Mukui, Guolian Industrial Investment, Tian Ge Interactive, etc. Proceeds from the financing will be used to accelerate the development of ongoing ...

Thursday, 15 July 2021, 4:05 pm Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. Co-led by SDIC Fund Management and Tigermed, this round of financing is participated by Legend Star, Wuxi Biologicals Healthcare Ventures, Triwise Capital, Qingdao Mukui, Guolian Industrial Investment, Tian Ge Interactive, etc. Proceeds from the financing will be used to accelerate the development of ongoing clinical and preclinical programs, e...